"Comparison of of Volume-Controlled Ventilation and Pressure-Controlled Ventilation Modes in Laparoscopic Cholecystectomy" (VCV VS PCV)

November 9, 2026 updated by: Mehreen Mirza

"Comparison of the Effects of Volume-Controlled Ventilation and Pressure-Controlled Ventilation Modes on Compliance and End-Tidal CO2 In Patients Undergoing Laparoscopic Cholecystectomy"

This randomized controlled trial compares volume-controlled ventilation and pressure-controlled ventilation in adult patients undergoing elective laparoscopic cholecystectomy under general anesthesia. The study evaluates the effects of both ventilation modes on static lung compliance and end-tidal carbon dioxide at predefined intraoperative time points. The objective is to determine whether pressure-controlled ventilation provides improved respiratory mechanics and more effective ventilation compared with volume-controlled ventilation during laparoscopic surgery.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Laparoscopic cholecystectomy is commonly performed under general anesthesia with carbon dioxide pneumoperitoneum. Increased intra-abdominal pressure during pneumoperitoneum can alter respiratory mechanics, reduce lung compliance, and increase airway pressures. These physiological changes may affect ventilation and gas exchange during laparoscopic procedures.

This randomized controlled trial is designed to compare two commonly used mechanical ventilation strategies: volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV). Participants are randomly allocated in a 1:1 ratio to receive either ventilation mode during elective laparoscopic cholecystectomy. A standardized general anesthetic technique and consistent intraoperative ventilation targets are maintained in both groups to minimize variations in perioperative management.

In the VCV group, ventilation is delivered using a preset tidal volume, whereas in the PCV group, inspiratory pressure is adjusted to achieve the target tidal volume. The ventilation protocol includes a tidal volume of 8 mL/kg, an initial respiratory rate of 12 breaths per minute with subsequent adjustment according to end-tidal carbon dioxide levels, an inspiratory-to-expiratory ratio of 1:2, a positive end-expiratory pressure (PEEP) of 5 cmH₂O, and an inspired oxygen concentration (FiO₂) of 40%.

Intraoperative respiratory parameters, including static lung compliance and end-tidal carbon dioxide (EtCO₂), are assessed at predefined stages of the procedure: five minutes after induction of anesthesia, fifteen minutes after carbon dioxide insufflation in the Trendelenburg position, and ten minutes after carbon dioxide desufflation. Measurements are obtained using the integrated monitoring system of the anesthesia workstation.

The study aims to evaluate the physiological effects of the two ventilation strategies during laparoscopic surgery and determine whether either approach offers advantages in maintaining respiratory mechanics and adequate ventilation. The findings may contribute to evidence-based selection of mechanical ventilation strategies for patients undergoing elective laparoscopic cholecystectomy.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab Province
      • Multan, Punjab Province, Pakistan, 00000
        • Nishtar Medical University and Hospital, Multan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult patients aged 25-50 years.
  • Either sex.
  • ASA physical status I or II.
  • Scheduled for elective laparoscopic cholecystectomy under general anaesthesia.
  • Written informed consent obtained.

Exclusion Criteria:

  • ASA physical status III or IV.
  • Body mass index (BMI) greater than 35 kg/m².
  • Significant pulmonary disease (e.g., COPD, asthma, restrictive lung disease).
  • Significant cardiovascular disease.
  • Pregnancy.
  • Previous upper abdominal surgery.
  • Conversion to open cholecystectomy.
  • Refusal to participate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Volume Controlled Ventilation

Participants receive volume-controlled ventilation during elective laparoscopic cholecystectomy under general anesthesia.

Mechanical ventilation delivered using the volume-controlled ventilation mode during elective laparoscopic cholecystectomy under general anesthesia. Ventilation is provided with a tidal volume of 8 mL/kg, respiratory rate adjusted to maintain end-tidal carbon dioxide between 32 and 38 mmHg, PEEP of 5 cmH₂O, FiO₂ of 0.40, and an inspiratory-to-expiratory ratio of 1:2 throughout the surgical procedure.

Experimental: Pressure Controlled Ventilation

Participants receive pressure-controlled ventilation during elective laparoscopic cholecystectomy under general anesthesia.

Mechanical ventilation delivered using the pressure-controlled ventilation mode during elective laparoscopic cholecystectomy under general anesthesia. Inspiratory pressure is adjusted to achieve a tidal volume of 8 mL/kg while maintaining end-tidal carbon dioxide between 32 and 38 mmHg, with PEEP of 5 cmH₂O, FiO₂ of 0.40, and an inspiratory-to-expiratory ratio of 1:2 throughout the surgical procedure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Static Lung Compliance
Time Frame: Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.

Comparison of static lung compliance between the volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV) groups during elective laparoscopic cholecystectomy under general anesthesia.

Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.
End-Tidal Carbon Dioxide (EtCO₂)
Time Frame: Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.

Comparison of end-tidal carbon dioxide (EtCO₂) levels between the VCV and PCV groups.

Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak Inspiratory Pressure
Time Frame: Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.

Comparison of peak inspiratory pressure between the VCV and PCV groups during laparoscopic cholecystectomy.

Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2026

Primary Completion (Actual)

June 30, 2026

Study Completion (Actual)

July 20, 2026

Study Registration Dates

First Submitted

July 8, 2026

First Submitted That Met QC Criteria

July 11, 2026

First Posted (Actual)

July 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 13, 2026

Last Update Submitted That Met QC Criteria

November 9, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 18717 / NMU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared because no formal data-sharing plan has been established. Participant confidentiality and institutional ethical requirements will be maintained.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.